FDA Approves Mylan's Generic Topamax
The FDA approved Mylan Laboratories Inc.'s (MYL) generic version of epilepsy drug Topamax lifting the stock price 61 cents to close at $15.69.
posted by FC Market News at 10:18 AM
Monday, September 10, 2007
Previous Posts
- Cardica Downgraded
- No Licensing Deal For Theravance
- Enzo's Patent Suit Dismissed
- Pozen To Receive Additional $10 Million
- Harley-Davidson Lowers Outlook
- Hollis-Eden Reports Positive Test Results
- China Technology To Enter Solar Sector
- Gold Prices Rise Above $700
- CDC Swings To Loss
- Alabama National To Be Acquired
0 Comments:
Post a Comment
<< Home